Trump order lowering tariffs on EU autos still days away, source says

The reduction of U.S. tariffs on European auto imports from 27.5% to the agreed 15% is delayed, as President Trump's July 31 executive order establishing a 15% baseline tariff for other goods specifically excluded products under Section 232 investigations, which include automobiles. Consequently, EU-made vehicles like BMW and Mercedes-Benz will continue to face the higher duties. While some goods like pharmaceuticals and semiconductors will see the 15% levy effective August 7, spirits and wines will also face increased interim duties of 15% as negotiations continue on a final product list.

Analysis

The anticipated reduction of U.S. tariffs on European auto imports from 27.5% to a previously agreed-upon 15% rate is facing a delay, creating near-term uncertainty for the sector. A recent executive order by President Trump, which established a 15% baseline tariff for many EU goods effective August 7, specifically excluded products under Section 232 investigations, a category that includes automobiles. Consequently, European manufacturers such as BMW, Mercedes-Benz, and Volvo will continue to face the higher 27.5% duty on their U.S. imports until a separate, legally binding order is issued. While the auto sector waits, the trade framework is progressing for other industries; U.S. tariffs on EU pharmaceuticals and semiconductors will be set at 15%, and duties on spirits and wines will also rise to 15% in the interim. The overall situation remains fluid as EU and U.S. officials are still negotiating a final list of products for either zero-for-zero or significantly lower tariff rates, with a senior EU official describing the joint statement as being at an "advanced" stage.

Key Decisions for Investors

• Investors with exposure to European automakers like BMW and Mercedes-Benz should recognize the continued margin pressure from the 27.5% tariff and monitor the timeline for the specific executive order as a key catalyst for the sector.
• The delay underscores the execution risk inherent in the current U.S.-EU trade negotiations; it may be prudent to hedge against further political or administrative postponements affecting the automotive supply chain.
• Consider the divergent impacts across sectors, as the implementation of a 15% tariff on pharmaceuticals and semiconductors contrasts with the ongoing uncertainty for autos, suggesting a need for sector-specific positioning rather than a broad European trade-based strategy.